Astral

As of the close on November 5, 2026, ASTRAL trades at ₹1388.0, reflecting a -2.5% daily decline and a -20.5% drawdown from its recent high. The technical setup is predominantly bearish across shorter timeframes: the stock is trading below all supplied moving averages (EMA/SMA 20/50/200) and the Supertrend indicator on daily and weekly charts. Daily trend strength is weak (ADX 18.1), with the minus DI (16.21) exceeding the plus DI (21.33), indicating selling pressure despite low conviction. Conversely, the monthly chart shows a bullish Supertrend direction, though price remains below key moving averages, suggesting a longer-term consolidation or reversal context.

Price positioning is near the lower end of its 252-day range (+16.7%) and mid-20-day range (+40.3%). Immediate resistance sits at ₹1391.13 (0.23% above), while support is found at ₹1386.4 (0.12% below). Recent anomalies include downward gaps on October 22 and 28, coinciding with inactive bearish candlestick patterns like Bearish Engulfing and Shooting Star formations in late October. Volatility is elevated at an annualized 29.9%, with an ATR of 2.74%. The setup remains unconfirmed as neutral; a sustained move above ₹1408.07 (1.45% resistance) would be required to challenge the short-term bearish structure, while a break below ₹1358.57 (2.12% support) could extend losses toward the next level at ₹1341.63.

Astral reported Q2 FY27 consolidated net profit of ₹127 crore, a 5.9% year-on-year decline driven by EBITDA margin contraction from 16.3% to 13.1%, despite robust 26.1% revenue growth. The company attributed margin pressure to rising polymer prices but expects recovery in Q3 after passing on cost hikes, while maintaining guidance for double-digit volume growth in plumbing. Management also announced an interim dividend of ₹1.50 per share and progress on a new CPVC resin plant, alongside a goodwill impairment charge related to its US subsidiary. Following the results, shares fell 12% to a fresh 52-week low. Analyst reactions were mixed: Prabhudas Lilladher issued a 'Buy' with a target of ₹1596, JPMorgan maintained an overweight stance at ₹1635, and CLSA held a 'Hold' view at ₹1460.

Astral reported unaudited financial results for Q2 and H1 FY2026-27 (ended September 30, 2026) on November 5, 2026. The company posted consolidated revenue growth of 26%, driven by a 19.1% increase in plumbing volumes. However, consolidated net profit declined 5.9% year-on-year to ₹127 crore, as EBITDA margins contracted to 13.1% from 16.3% in the prior year. Management attributed margin pressure to rising polymer prices but expects recovery in Q3 after passing on cost hikes.

The Board approved an interim dividend of ₹1.50 per share for FY2026-27, with a record date of November 13, 2026. Operational updates include capacity expansion in Pipes and Fittings, progress on Phase I of a new CPVC Resin backward integration plant, and the acquisition of a 60% interest in Differentiated & Sustainable Solutions LLP. Additionally, Mr. Ritesh Patel and Mr. Pritesh Shah were designated as Senior Management Personnel effective November 5, 2026.

Following the earnings release, Astral shares fell approximately 12%, hitting a fresh 52-week low. The price action reflects investor reaction to the profit decline and margin contraction despite strong top-line growth. Analysts remain divided: Prabhudas Lilladher issued a 'Buy' recommendation with a target price of ₹1,596, while JPMorgan and CLSA maintained Overweight and Hold stances with targets of ₹1,635 and ₹1,460 respectively.

Astral Limited’s Board approved unaudited financial results for Q2 and H1 FY 2026-27 (ended September 30, 2026) and declared an interim dividend of ₹1.50 per share. Consolidated revenue grew 26% and Plumbing volume increased 19.1% in Q2 FY27. The company is expanding Pipes and Fittings capacity, progressing with Phase I of a new CPVC Resin backward integration plant, and acquired a 60% interest in Differentiated & Sustainable Solutions LLP. Mr. Ritesh Patel and Mr. Pritesh Shah were designated as Senior Management Personnel effective November 5, 2026. The record date for the interim dividend is November 13, 2026.

Astral’s operating trajectory shows a clear recovery in profitability and cash generation, though leverage is rising. In Q2 FY2026-27, revenue increased sequentially to ₹2,000 crore from ₹1,591 crore in Q1, while net profit rose to ₹127 crore from ₹120 crore. This follows a strong annual trend where TTM sales reached ₹6,785 crore and TTM net profit hit ₹576 crore, up from ₹535 crore in Mar 2026.

Earnings quality has improved significantly; CFO/EBITDA conversion jumped to 123% in Mar 2026 from 85% in Mar 2025, supported by a sharp reduction in the Cash Conversion Cycle to 23 days. However, financial health faces pressure from higher borrowings, which rose to ₹250 crore in Mar 2026 from ₹119 crore in Mar 2024, coinciding with a decline in ROCE to 19%. Interest costs also climbed to ₹64 crore in Mar 2026. While promoter holding remains stable at 54.22%, Foreign Institutional Investors (FIIs) reduced their stake to 11.09% in Sep 2026, whereas Domestic Institutional Investors (DIIs) increased theirs to 23.76%.

The most important next checkpoint is whether Astral can sustain its margin expansion and cash conversion efficiency as it manages higher debt levels and interest expenses.

Astral's Q2 FY27 results highlight a divergence between top-line growth and bottom-line profitability, triggering significant market skepticism. While revenue expanded by 26.1%, consolidated net profit contracted by 5.9% year-on-year to ₹127 crore, driven by EBITDA margin compression from 16.3% to 13.1%. The company attributed this pressure to rising polymer costs, though it anticipates recovery in Q3 after passing on hikes. This earnings miss coincided with a sharp 12% single-day share decline and a drop to a fresh 52-week low.

Technically, the stock exhibits bearish momentum across daily and weekly timeframes, with the Supertrend indicator signaling downside pressure and short-term moving averages sloping negatively. The stock is currently trading at ₹1,388, reflecting a substantial drawdown of 20.5% from its peak, with a maximum historical drawdown of 25.0%. Volatility remains elevated at an annualized rate of 29.9%. Although analysts maintain target prices ranging from ₹1,460 to ₹1,635, the immediate price action suggests investors are prioritizing margin stability over volume growth guidance.